Все публикации

Dr. Niti Raizada shares the benefits of using Guardant360 TissueNext™

Guardant Health’s Shield™ blood test receives US FDA Approval

How do you choose the right liquid biopsy test for patients with cancer?

How do liquid biopsies help guide treatment decisions for patients with cancer?

Dr. Shaheenah Dawood sharing the benefits of MRD detection in CRC

Indian doctors share how liquid biopsies guide treatment decisions across the cancer care continuum

Indian medical oncologists sharing clinical experiences of using liquid biopsies

Remembering Cancer Survivors Month

Leading Medical Oncologists Sharing Why Liquid Biopsies are a Solid Alternative to Tissue Genotyping

Expert Opinion | Dr. Clara Montagut | The challenges in detecting MRD in localized colon cancer

Expert Opinion | Dr. Nir Peled | Liquid biopsy as a first line diagnostic tool for NSCLC patients

Expert Opinion | Dr. Manish Singhal | Liquid biopsies which can provide information on TMB

Guardant by the Bay with Singapore Cancer Society beneficiaries

Expert Opinion | Dr. Sewanti Limaye | Advantages of using complementary testing in NSCLC

Guardant Health AMEA wins Team of the Year in Healthcare Technology

Expert Opinion | Dr. Amit Rauthan | Benefits of using the plasma-first approach for NSCLC patients

Patient education video featuring Dr. Thomas Soh from OncoCare Cancer Centre

Expert Opinion | Dr. Nitesh Rohatgi | The importance of ctDNA-based response monitoring

Guardant Health AMEA wins Oncology Product Innovation of the Year - Asia

Expert Opinion | Role of liquid biopsy in lung cancer | Prof. Nir Peled

Dr. T. Raja talks about using the Guardant Reveal test for the detection of MRD

Prof. Arkenau speaks about using Guardant360® for patients with advanced gastrointestinal cancer.

Guardant Health transforming cancer care at all stages of the disease

Patient education video featuring Dr. Akhil Chopra from OncoCare Cancer Centre